Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/50155

Full metadata record
DC FieldValueLanguage
dc.contributor.authorCastro, Lisandrapor
dc.contributor.authorAlves, Sarapor
dc.contributor.authorChaves, Susana R.por
dc.contributor.authorCosta, Jose Luispor
dc.contributor.authorSoares, Paulapor
dc.contributor.authorPreto, Anapor
dc.date.accessioned2018-02-07T11:43:16Z-
dc.date.issued2015-11-05-
dc.identifier.issn0303-7207por
dc.identifier.urihttp://hdl.handle.net/1822/50155-
dc.description.abstractThyroid cancer (TC) is frequently associated with BRAF or RAS oncogenic mutations and RET/PTC rear-rangements, with aberrant RAF-MEK-ERK and/or PI3K pathway activation. BRAF underlies ERR activation in most TC cells, but not in TPC-1 cells with RET/PTC1 rearrangement. Here, we show that depletion of RAF-1, a RAF family member with a poorly defined role in TC, decreases proliferation and increases apoptosis in TPC-1 cells and, less significantly, in cells harboring a BRAF(V600E) or HRAS(G13R) mutations, but without affecting ERR activation. We further demonstrate that constitutive activation of ERKs in TPC-1 cells is not caused by mutations in 50 oncogenes and tumor suppressors prone to activate the ERR pathway, or affected by inhibition of BRAF, MEK1/2 or PI3K. Our data indicate that RAF-1 is important for the survival of TPC-1 cells independently of the classical MEK1/2-ERK activation, offering new perspectives on RET/PTC signaling and for the therapy of thyroid cancers. (C) 2015 Elsevier Ireland Ltd. All rights reserved.por
dc.description.sponsorship- This work was supported by the Portuguese Foundation for Science and Technology (FCT) I.P. through the strategic funding UID/BIA/04050/2013, projects PEst-C/SAU/LA0003/2013 and FCTANR/BEX-BCM/0175/2012, as well as fellowships to L. Castro (SFRH/BD/93589/2013), S. Alves (SFRH/BD/64695/2009) and S. Chaves (SFRH/BPD/89980/2012). This work was also supported by FEDER through POFC - COMPETE. Further funding was obtained from the project "Microenvironment, metabolism and cancer" that was partially supported by Programa Operacional Regional do Norte (ON.2 - O Novo Norte) under the Quadro de Referencia Estrategico Nacional (QREN) and the Fundo Europeu de Desenvolvimento Regional (FEDER). IPATIMUP integrates the i3S Research Unit, which is partially supported by FCT.por
dc.language.isoengpor
dc.publisherElsevierpor
dc.relationinfo:eu-repo/grantAgreement/FCT/5876/147364/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/COMPETE/132983/PTpor
dc.relationFCTANR/BEX-BCM/0175/2012por
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F93589%2F2013/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F64695%2F2009/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBPD%2F89980%2F2012/PTpor
dc.rightsclosedAccesspor
dc.subjectThyroid cancerpor
dc.subjectRAF-1por
dc.subjectBRAFpor
dc.subjectRET/PTC1por
dc.subjectPI3K-AKTpor
dc.subjectERKpor
dc.titleRAF-1 promotes survival of thyroid cancer cells harboring RET/PTC1 rearrangement independently of ERK activationpor
dc.typearticle-
dc.peerreviewedyespor
oaire.citationStartPage64por
oaire.citationEndPage75por
oaire.citationIssueCpor
oaire.citationVolume415por
dc.date.updated2018-02-07T01:34:27Z-
dc.identifier.essn1872-8057por
dc.identifier.doi10.1016/j.mce.2015.08.006por
dc.identifier.pmid26265449-
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersionpor
dc.subject.wosScience & Technology-
sdum.export.identifier2540-
sdum.journalMolecular and Cellular Endocrinologypor
Appears in Collections:DBio - Artigos/Papers

Files in This Item:
File Description SizeFormat 
Castro L MCE last 1-s2.0-S0303720715300460-main 22 set15.pdf
  Restricted access
3,45 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID